Eikon Therapeutics, Inc. (EIKN) Cash flow

27 Followers

Eikon Therapeutics, Inc. Cash Flow

EIKN's free cash flow for Q2 2026 was $-65.21M. For the 2026 fiscal year, EIKN's free cash flow was decreased by $― and operating cash flow was $-64.96M. See a summary of the company’s cash flow.

Cash Flow	Dec 25
Operating Cash Flow	$ -188.52M
Investing Cash Flow	$ -181.34M
Financing Cash Flow	$ 352.05M
End Cash Position	$ 113.07M
Free Cash Flow	$ -235.26M

Currency in USD